Skip to main content
Clinical Trials/NL-OMON32647
NL-OMON32647
Withdrawn
Not Applicable

Decreasing acute peripheral neuropathy in patients treated with Oxaliplatin (heated oxaliplatin versus oxaliplatin on room temperature) - heated oxaliplatin versus oxaliplatin on room temperature

Sint Antonius Ziekenhuis0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
acute peripheral neuropathy
Sponsor
Sint Antonius Ziekenhuis
Enrollment
30
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18 \- 70 years
  • Treated with Oxaliplatin mono or in combination with other chemotherapeutical drugs or angiogenesis inhibitors.
  • Adjuvant or palliative treatment for colorectal carcinoma
  • Patients live within a radius of 30 km from the hospital

Exclusion Criteria

  • Patients with diabetes mellitus, renal failure, alcoholism, vitamin B 12 deficiency, other neoplasm and HIV.
  • Patients who are treated in an early stage, with a cytostatic with a neurotoxicity profile.
  • Patients with an already existing peripheral neuropathy
  • Patients with congenital peripheral neuropathy

Outcomes

Primary Outcomes

Not specified

Similar Trials